CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
nutritional herbal extract from Salacia oblongadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00306072
NCT00306072Phase 2Completed
CompareCT.gov

Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes

Ross Products·interventional·Posted Mar 22, 2006·Updated Jan 27, 2010

In Brief

A Phase 2 clinical trial evaluating nutritional herbal extract from Salacia oblonga for Diabetes Mellitus. Completed, across 2 sites.

Detailed Summary

The purpose of this study is to evaluate two levels of the herbal extract Salacia oblonga (salacinol) on postprandial glycemia and insulinemia in patients with Type 2 diabetes after ingestion of a high-carbohydrate control meal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 22, 2006
Enrollment StartJun 1, 2005
Study CompletionSep 1, 2005
TodayJul 2, 2026
Posted 20.3 years ago

Interventions

nutritional herbal extract from Salacia oblongadrug